Literature DB >> 16156328

The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access.

Christopher J Crnich1, Jeremy A Halfmann, Wendy C Crone, Dennis G Maki.   

Abstract

BACKGROUND: Products containing alcohol are commonly used with intravascular devices at insertion, to remove lipids from occluded intravascular devices used during parenteral nutrition, and increasingly for the prevention and treatment of intravascular device-related bloodstream infection. The effects of alcohol on the integrity of intravascular devices remain unknown.
METHODS: Two types of widely used commercial peripherally inserted central catheters, one made of polyetherurethane and one made of silicone, were exposed to a 70% ethanol lock solution for up to 10 weeks. Mechanical testing was performed to identify force-at-break, stress, strain, modulus of elasticity, modulus of toughness, and wall area of ethanol-exposed and control catheters.
RESULTS: No significant differences between exposed and unexposed catheters were identified for any of the mechanical parameters tested except for a marginal reduction in the modulus of elasticity for both polyetherurethane and silicone catheters and minor increases in the wall area of polyetherurethane catheters.
CONCLUSIONS: These data indicate that exposure to a 70% ethanol lock solution does not appreciably alter the integrity of selected commercial polyetherurethane and silicone catheters. Given the greatly expanded use of alcoholic solutions with intravascular devices of all types, we believe that manufacturers would be well advised to subject their catheters and other intravascular devices to formal testing of the type employed in this study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156328     DOI: 10.1086/502607

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  21 in total

1.  Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.

Authors:  Mark L Kayton; Edward G Garmey; Nicole M Ishill; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Carol Rossetto; Courtney Hennelly; Melissa Parra Doyle; Shoshana Rosenberg; Olga Santoro; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

2.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

3.  Variables decreasing tip movement of peripherally inserted central catheters in pediatric patients.

Authors:  Ralph Gnannt; Bairbre L Connolly; Dimitri A Parra; Joao Amaral; Rahim Moineddin; Avnesh S Thakor
Journal:  Pediatr Radiol       Date:  2016-06-07

4.  Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.

Authors:  Daniel L Landry; Gregory L Braden; Stephen L Gobeille; Sarah D Haessler; Chirag K Vaidya; Stephen J Sweet
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

5.  Reducing catheter-related infections in hemodialysis patients.

Authors:  Daniel Landry; Gregory Braden
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-26       Impact factor: 8.237

6.  Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy.

Authors:  David W Kubiak; Erin T Gilmore; Mary W Buckley; Robert Lynch; Francisco M Marty; Sophia Koo
Journal:  J Antimicrob Chemother       Date:  2014-02-12       Impact factor: 5.790

7.  Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.

Authors:  Lennert Slobbe; Jeanette K Doorduijn; Pieternella J Lugtenburg; Abdelilah El Barzouhi; Eric Boersma; Willem B van Leeuwen; Bart J A Rijnders
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms.

Authors:  Brian M Peters; Raven M Ward; Hallie S Rane; Samuel A Lee; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

9.  Ethanol Lock Efficacy and Associated Complications in Children With Intestinal Failure.

Authors:  Ethan A Mezoff; Lin Fei; Misty Troutt; Kim Klotz; Samuel A Kocoshis; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-02-23       Impact factor: 4.016

10.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.